David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.55% |
| 2 | Consumer Discretionary | 8.97% |
| 3 | Financials | 8.5% |
| 4 | Healthcare | 8.44% |
| 5 | Industrials | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4026
CALL
PAR Technology
PAR
$804M
| $252K | ﹤0.01% |
18,900
-2,100
| -10% | -$49.3K |
|
4027
MBIA
MBI
$250M
| $252K | ﹤0.01% |
42,616
-19,987
| -32% | -$127K |
|
4028
Invesco S&P 500 High Beta ETF
SPHB
$928M
| $251K | ﹤0.01% |
2,168
-500
| -19% | -$60.5K |
|
4029
Oil-Dri
ODC
$1.34B
| $251K | ﹤0.01% |
3,859
-8,032
| -68% | -$489K |
|
4030
CALL
Titan Machinery
TITN
$444M
| $251K | ﹤0.01% |
15,000
+4,800
| +47% | +$83.3K |
|
4031
American Public Education
APEI
$846M
| $250K | ﹤0.01% |
+4,390
| New | +$201K |
|
4032
Fidelity MSCI Communication Services Index ETF
FCOM
$1.78B
| $249K | ﹤0.01% |
+3,655
| New | +$263K |
|
4033
Corbus Pharmaceuticals
CRBP
$207M
| $249K | ﹤0.01% |
26,474
-2,320
| -8% | -$19.5K |
|
4034
PUT
Zoetis
ZTS
$31.9B
| $248K | ﹤0.01% |
2,100
| – | – |
|
|
BTGO
4035
BitGo Holdings
BTGO
$799M
| $248K | ﹤0.01% |
+30,094
| New | +$329K |
|
4036
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
| $247K | ﹤0.01% |
4,700
| – | – |
|
4037
Transmedics
TMDX
$3.25B
| $247K | ﹤0.01% |
+2,481
| New | +$324K |
|
4038
Sierra Bancorp
BSRR
$514M
| $246K | ﹤0.01% |
7,256
-2,735
| -27% | -$95.6K |
|
4039
PUT
Thermo Fisher Scientific
TMO
$232B
| $246K | ﹤0.01% |
500
-6,100
| -92% | -$3.31M |
|
4040
CALL
Hawkins
HWKN
$2.46B
| $246K | ﹤0.01% |
1,600
-900
| -36% | -$132K |
|
4041
Hilton Worldwide
HLT
$74.3B
| $245K | ﹤0.01% |
807
-26,862
| -97% | -$8.14M |
|
4042
Provident Financial Services
PFS
$3.07B
| $245K | ﹤0.01% |
+11,572
| New | +$247K |
|
|
ACB
4043
Aurora Cannabis
ACB
$249M
| $243K | ﹤0.01% |
74,117
-1,941
| -3% | -$7.33K |
|
4044
CALL
Dutch Bros
BROS
$7.17B
| $243K | ﹤0.01% |
4,800
-142,100
| -97% | -$7.77M |
|
4045
Ascendis Pharma A/S
ASND
$16.5B
| $243K | ﹤0.01% |
1,062
-124,706
| -99% | -$28M |
|
4046
CALL
Transcat
TRNS
$818M
| $242K | ﹤0.01% |
3,300
-11,200
| -77% | -$788K |
|
|
HVIIR
4047
Hennessy Capital Investment Corp VII Rights
HVIIR
| $242K | ﹤0.01% |
850,000
| – | – |
|
4048
AB Disruptors ETF
FWD
$3.12B
| $242K | ﹤0.01% |
2,227
| – | – |
|
|
UHT
4049
Universal Health Realty Income Trust
UHT
$582M
| $241K | ﹤0.01% |
+5,963
| New | +$247K |
|
4050
Hackett Group
HCKT
$276M
| $241K | ﹤0.01% |
18,534
-69,402
| -79% | -$1.11M |
|
Similar funds
David Shaw's Q1 2026 Portfolio in Review
As of Q1 2026, David Shaw held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15.1B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, David Shaw opened a new position in Venture Global Inc worth $211M.
- David Shaw's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- David Shaw added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- David Shaw's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- David Shaw's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- David Shaw opened 685 new positions and closed 756 in Q1 2026.
- David Shaw's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.